Home NDC 64980-183 Tranylcypromine Sulfate
Product NDC 64980-183
11-digit product format 649800183
Labeler code 64980
Product ID 64980-183_f1959810-01c4-4cfd-a729-97d7b37d6654
Type HUMAN PRESCRIPTION DRUG
Nonproprietary name tranylcypromine sulfate
Dosage form TABLET
Route ORAL
Labeler Rising Pharmaceuticals, Inc.
Application NDA012342
Marketing category NDA
Marketing start 2012-01-09
Marketing end 0000-00-00
Substance TRANYLCYPROMINE SULFATE
Active strength 10 mg/1
Pharmacologic classes Monoamine Oxidase Inhibitor [EPC],Monoamine Oxidase Inhibitors [MoA]
NDC exclude flag No
Listing certified through 2019-12-31
Current FDA listing Historical FDA.report record Observed NDC auxiliary status history# This history shows the information present in each captured FDA auxiliary file. It is not a continuous regulatory timeline, and a missing record does not establish a status.
Historic NDC status page 1 of 1 · 38 matching rows.
View current auxiliary records. · View the auxiliary file history.
Captured / source date, Dataset, Scope table Captured / source date Dataset Scope Package NDC Code Status Snapshot Source SHA-256 2025-12-14 17:58 UTC · source 2025-12-05 excluded product product D Discontinued by firm d630ba8d3edf…732f749b63fb…2025-12-14 17:58 UTC · source 2025-12-05 excluded package package 64980-183-01 D Discontinued by firm d630ba8d3edf…732f749b63fb…2025-08-27 00:01 UTC · source 2025-08-26 excluded product product D Discontinued by firm f5e01cc5f278…a2eaf40c39c3…2025-08-27 00:01 UTC · source 2025-08-26 excluded package package 64980-183-01 D Discontinued by firm f5e01cc5f278…a2eaf40c39c3…2025-04-01 02:39 UTC · source 2025-03-31 excluded product product D Discontinued by firm 2ef7874e63bc…57b86245f4fa…2025-04-01 02:39 UTC · source 2025-03-31 excluded package package 64980-183-01 D Discontinued by firm 2ef7874e63bc…57b86245f4fa…2025-03-28 20:22 UTC · source 2025-03-28 excluded product product D Discontinued by firm a1b67e2a42f9…c4cf2c586c0d…2025-03-28 20:22 UTC · source 2025-03-28 excluded package package 64980-183-01 D Discontinued by firm a1b67e2a42f9…c4cf2c586c0d…2025-03-22 03:12 UTC · source 2025-03-21 excluded product product D Discontinued by firm cfe11265f3b6…090c488252e2…2025-03-22 03:12 UTC · source 2025-03-21 excluded package package 64980-183-01 D Discontinued by firm cfe11265f3b6…090c488252e2…2025-03-10 12:48 UTC · source 2025-03-10 excluded product product D Discontinued by firm cdf11ea48f46…ba0047e9e063…2025-03-10 12:48 UTC · source 2025-03-10 excluded package package 64980-183-01 D Discontinued by firm cdf11ea48f46…ba0047e9e063…2025-02-02 03:52 UTC · source 2025-01-31 excluded product product D Discontinued by firm 302b2466d912…e7b80fea0513…2025-02-02 03:52 UTC · source 2025-01-31 excluded package package 64980-183-01 D Discontinued by firm 302b2466d912…e7b80fea0513…2025-01-20 13:05 UTC · source 2025-01-20 excluded product product D Discontinued by firm ed331223b511…672a5bd82f5f…2025-01-20 13:05 UTC · source 2025-01-20 excluded package package 64980-183-01 D Discontinued by firm ed331223b511…672a5bd82f5f…2025-01-11 03:41 UTC · source 2025-01-10 excluded product product D Discontinued by firm 0efc9e666f02…f202fb6c5f17…2025-01-11 03:41 UTC · source 2025-01-10 excluded package package 64980-183-01 D Discontinued by firm 0efc9e666f02…f202fb6c5f17…2024-11-09 02:27 UTC · source 2024-11-08 excluded product product D Discontinued by firm ad56d346431e…cc804d4bbf1e…2024-11-09 02:27 UTC · source 2024-11-08 excluded package package 64980-183-01 D Discontinued by firm ad56d346431e…cc804d4bbf1e…2024-10-04 04:10 UTC · source 2024-10-03 excluded product product D Discontinued by firm 367a005e9d99…383a685ebd0f…2024-10-04 04:10 UTC · source 2024-10-03 excluded package package 64980-183-01 D Discontinued by firm 367a005e9d99…383a685ebd0f…2024-07-10 04:00 UTC · source 2024-07-09 excluded product product D Discontinued by firm 557ba5c1ecfa…9c80585c8c6e…2024-07-10 04:00 UTC · source 2024-07-09 excluded package package 64980-183-01 D Discontinued by firm 557ba5c1ecfa…9c80585c8c6e…2024-03-11 06:39 UTC · source 2024-03-08 excluded product product I Inactivated by FDA 1332a3947898…d4bfe170f9cd…2024-03-11 06:39 UTC · source 2024-03-08 excluded package package 64980-183-01 I Inactivated by FDA 1332a3947898…d4bfe170f9cd…2022-08-30 03:57 UTC · source 2022-08-29 excluded product product I Inactivated by FDA fb8cb913e6d1…eb8c232b6be0…2022-08-30 03:57 UTC · source 2022-08-29 excluded package package 64980-183-01 I Inactivated by FDA fb8cb913e6d1…eb8c232b6be0…2022-04-09 23:13 UTC · source 2022-04-08 excluded product product I Inactivated by FDA 86f5da6cb304…a595104c45d7…2022-04-09 23:13 UTC · source 2022-04-08 excluded package package 64980-183-01 I Inactivated by FDA 86f5da6cb304…a595104c45d7…2022-04-04 05:40 UTC · source 2022-04-01 excluded product product I Inactivated by FDA bd6a592717d7…303034d00443…2022-04-04 05:40 UTC · source 2022-04-01 excluded package package 64980-183-01 I Inactivated by FDA bd6a592717d7…303034d00443…2021-12-27 23:28 UTC · source 2021-12-27 excluded product product I Inactivated by FDA 8dfbde2a14a4…c9ff85d89658…2021-12-27 23:28 UTC · source 2021-12-27 excluded package package 64980-183-01 I Inactivated by FDA 8dfbde2a14a4…c9ff85d89658…2020-12-18 03:04 UTC · source 2020-12-17 excluded product product I Inactivated by FDA e2bbac7714bc…27bdfed8d636…2020-12-18 03:04 UTC · source 2020-12-17 excluded package package 64980-183-01 I Inactivated by FDA e2bbac7714bc…27bdfed8d636…2020-06-10 20:45 UTC · source 2020-06-10 excluded product product I Inactivated by FDA 9bebd1f3094a…5416666fcb17…2020-06-10 20:45 UTC · source 2020-06-10 excluded package package 64980-183-01 I Inactivated by FDA 9bebd1f3094a…5416666fcb17…
Source provenance: Browse the complete Orange Book source catalog · source snapshot 42 .
Orange Book products# Current product rows page 1 of 1 · 1 matching rows.
Application-product, Trade name, Ingredient table Application-product Trade name Ingredient Strength Dosage form / route TE codes RLD / RS Approval date N012342-003 PARNATE TRANYLCYPROMINE SULFATE EQ 10MG BASE TABLET / ORAL AB RLD, RS 1985-08-16
Therapeutic equivalence codes# Current TE-code rows page 1 of 1 · 1 matching rows.
Application-product, TE code table Application-product TE code N012342-003 AB
Observed Orange Book product history# Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.
Product history page 1 of 2 · 42 observed states.
Captured, Edition, Application-product table Captured Edition Application-product Trade name Strength Dosage form / route Product TE source text RLD / RS Approval date Source SHA-256 2026-08-18 06:07:40 2026-07 N012342-003 PARNATE EQ 10MG BASE TABLET / ORAL AB RLD, RS 1985-08-16 caaa826d4ba7…2026-02-19 14:30 UTC 2026-02 N012342-003 PARNATE EQ 10MG BASE TABLET / ORAL AB RLD, RS 1985-08-16 011fe1cb6892…2025-12-14 10:44 UTC · 2 captures of this ZIP 2025-12 N012342-003 PARNATE EQ 10MG BASE TABLET / ORAL AB RLD, RS 1985-08-16 31067a03dcf5…2025-08-23 18:47 UTC 2025-08 N012342-003 PARNATE EQ 10MG BASE TABLET / ORAL AB RLD, RS 1985-08-16 6a471c1ec25d…2025-03-22 03:13 UTC · 3 captures of this ZIP 2025-03 N012342-003 PARNATE EQ 10MG BASE TABLET / ORAL AB RLD, RS 1985-08-16 fd3edfee7708…2025-02-26 10:13 UTC · 3 captures of this ZIP 2025-02 N012342-003 PARNATE EQ 10MG BASE TABLET / ORAL AB RLD, RS 1985-08-16 b8a1b40f171c…2025-01-19 17:59 UTC · 7 captures of this ZIP 2025-01 N012342-003 PARNATE EQ 10MG BASE TABLET / ORAL AB RLD, RS 1985-08-16 03ed91905a0d…2024-12-13 21:23 UTC · 2 captures of this ZIP 2024-12 N012342-003 PARNATE EQ 10MG BASE TABLET / ORAL AB RLD, RS 1985-08-16 2680178bc6a6…2024-09-14 05:58 UTC · 2 captures of this ZIP 2024-09 N012342-003 PARNATE EQ 10MG BASE TABLET / ORAL AB RLD, RS 1985-08-16 5bbf6a4d5a75…2024-11-08 22:44 UTC · 3 captures of this ZIP 2024-11 N012342-003 PARNATE EQ 10MG BASE TABLET / ORAL AB RLD, RS 1985-08-16 d8e5a09893c0…2024-10-29 15:01 UTC 2024-10 N012342-003 PARNATE EQ 10MG BASE TABLET / ORAL AB RLD, RS 1985-08-16 d06236e962d9…2024-08-13 05:28 UTC · 3 captures of this ZIP 2024-08 N012342-003 PARNATE EQ 10MG BASE TABLET / ORAL AB RLD, RS 1985-08-16 79d66fd596c7…2024-07-13 05:37 UTC · 2 captures of this ZIP 2024-07 N012342-003 PARNATE EQ 10MG BASE TABLET / ORAL AB RLD, RS 1985-08-16 301d65b070ca…2024-06-18 03:08 UTC · 5 captures of this ZIP 2024-06 N012342-003 PARNATE EQ 10MG BASE TABLET / ORAL AB RLD, RS 1985-08-16 1e350fbaab3a…2024-05-31 18:47 UTC 2024-05 N012342-003 PARNATE EQ 10MG BASE TABLET / ORAL AB RLD, RS 1985-08-16 8072bd15b7f6…2022-06-29 02:47 UTC · 2 captures of this ZIP 2022-06 N012342-003 PARNATE EQ 10MG BASE TABLET / ORAL AB RLD, RS 1985-08-16 5c6f7cd8ea54…2022-04-08 23:34 UTC 2022-04 N012342-003 PARNATE EQ 10MG BASE TABLET / ORAL AB RLD, RS 1985-08-16 5d02ea3f76ae…2022-04-04 05:41 UTC 2022-04 N012342-003 PARNATE EQ 10MG BASE TABLET / ORAL AB RLD, RS 1985-08-16 4b0b4de00fa7…2019-12-13 00:20 UTC 2019-12 N012342-003 PARNATE EQ 10MG BASE TABLET / ORAL AB RLD, RS 1985-08-16 74a2ff9319b5…2022-03-09 01:35 UTC 2022-03 N012342-003 PARNATE EQ 10MG BASE TABLET / ORAL AB RLD, RS 1985-08-16 bb7c543d1eb4…2021-12-28 21:50 UTC 2021-12 N012342-003 PARNATE EQ 10MG BASE TABLET / ORAL AB RLD, RS 1985-08-16 782e0a99824c…2021-05-05 16:15 UTC · 3 captures of this ZIP 2021-05 N012342-003 PARNATE EQ 10MG BASE TABLET / ORAL AB RLD, RS 1985-08-16 87673890dc5c…2021-03-12 10:30 UTC 2021-03 N012342-003 PARNATE EQ 10MG BASE TABLET / ORAL AB RLD, RS 1985-08-16 5aa47cf7b7d7…2020-12-22 03:56 UTC 2020-12 N012342-003 PARNATE EQ 10MG BASE TABLET / ORAL AB RLD, RS 1985-08-16 8869cabd3fbd…2020-11-12 02:37 UTC 2020-11 N012342-003 PARNATE EQ 10MG BASE TABLET / ORAL AB RLD, RS 1985-08-16 c0c555d07b60…2019-12-14 00:12 UTC 2019-12 N012342-003 PARNATE EQ 10MG BASE TABLET / ORAL AB RLD, RS 1985-08-16 3f01610625f2…2019-09-15 20:21 UTC 2019-09 N012342-003 PARNATE EQ 10MG BASE TABLET / ORAL AB RLD, RS 1985-08-16 b00525d2431f…2019-07-19 19:46 UTC 2019-07 N012342-003 PARNATE EQ 10MG BASE TABLET / ORAL AB RLD, RS 1985-08-16 ea99ee380514…2024-03-16 18:09 UTC · 4 captures of this ZIP 2024-03 N012342-003 PARNATE EQ 10MG BASE TABLET / ORAL AB RLD, RS 1985-08-16 6a51e52b5d6a…2024-02-18 07:12 UTC 2024-02 N012342-003 PARNATE EQ 10MG BASE TABLET / ORAL AB RLD, RS 1985-08-16 1c564ffb4f44…2023-12-20 04:57 UTC 2023-12 N012342-003 PARNATE EQ 10MG BASE TABLET / ORAL AB RLD, RS 1985-08-16 ea1830bbd6c7…2023-11-28 05:40 UTC · 2 captures of this ZIP 2023-11 N012342-003 PARNATE EQ 10MG BASE TABLET / ORAL AB RLD, RS 1985-08-16 a72a2bbeb626…2023-10-25 00:34 UTC · 2 captures of this ZIP 2023-10 N012342-003 PARNATE EQ 10MG BASE TABLET / ORAL AB RLD, RS 1985-08-16 9b2671bbb829…2023-07-15 15:27 UTC · 2 captures of this ZIP 2023-07 N012342-003 PARNATE EQ 10MG BASE TABLET / ORAL AB RLD, RS 1985-08-16 a67488948f0b…2023-06-13 01:57 UTC · 3 captures of this ZIP 2023-06 N012342-003 PARNATE EQ 10MG BASE TABLET / ORAL AB RLD, RS 1985-08-16 3f0d92c62455…2023-05-13 08:27 UTC 2023-05 N012342-003 PARNATE EQ 10MG BASE TABLET / ORAL AB RLD, RS 1985-08-16 053a50430f4f…2023-01-26 05:58 UTC 2023-01 N012342-003 PARNATE EQ 10MG BASE TABLET / ORAL AB RLD, RS 1985-08-16 3bdfa0b2c4d7…2022-11-12 20:34 UTC · 5 captures of this ZIP 2022-11 N012342-003 PARNATE EQ 10MG BASE TABLET / ORAL AB RLD, RS 1985-08-16 3a93d1ddd44b…2022-10-28 04:53 UTC 2022-10 N012342-003 PARNATE EQ 10MG BASE TABLET / ORAL AB RLD, RS 1985-08-16 f41ea6bd6efb…2022-09-29 23:25 UTC 2022-09 N012342-003 PARNATE EQ 10MG BASE TABLET / ORAL AB RLD, RS 1985-08-16 e64feba35796…
Observed Orange Book normalized TE history# Normalized TE history page 1 of 2 · 42 observed states.
FDA-Initiated Inactive NDC Indexing# DailyMed Socrata Ingredients# Ingredient, Type, UNII table Ingredient Type UNII DailyMed label SPL version Uploaded TRANYLCYPROMINE SULFATE ACTIVE INGREDIENT 7ZAT6ES870 TRANYLCYPROMINE SULFATE (TRANYLCYPROMINE SULFATE) TABLET [RISING PHARMACEUTICALS, INC.] 2 TRANYLCYPROMINE ACTIVE MOIETY 3E3V44J4Z9 TRANYLCYPROMINE SULFATE (TRANYLCYPROMINE SULFATE) TABLET [RISING PHARMACEUTICALS, INC.] 2 CELLULOSE, MICROCRYSTALLINE INACTIVE INGREDIENT OP1R32D61U TRANYLCYPROMINE SULFATE (TRANYLCYPROMINE SULFATE) TABLET [RISING PHARMACEUTICALS, INC.] 2 CITRIC ACID MONOHYDRATE INACTIVE INGREDIENT 2968PHW8QP TRANYLCYPROMINE SULFATE (TRANYLCYPROMINE SULFATE) TABLET [RISING PHARMACEUTICALS, INC.] 2 CROSCARMELLOSE SODIUM INACTIVE INGREDIENT M28OL1HH48 TRANYLCYPROMINE SULFATE (TRANYLCYPROMINE SULFATE) TABLET [RISING PHARMACEUTICALS, INC.] 2 D&C RED NO. 7 INACTIVE INGREDIENT ECW0LZ41X8 TRANYLCYPROMINE SULFATE (TRANYLCYPROMINE SULFATE) TABLET [RISING PHARMACEUTICALS, INC.] 2 FD&C BLUE NO. 2 INACTIVE INGREDIENT L06K8R7DQK TRANYLCYPROMINE SULFATE (TRANYLCYPROMINE SULFATE) TABLET [RISING PHARMACEUTICALS, INC.] 2 FD&C RED NO. 40 INACTIVE INGREDIENT WZB9127XOA TRANYLCYPROMINE SULFATE (TRANYLCYPROMINE SULFATE) TABLET [RISING PHARMACEUTICALS, INC.] 2 FD&C YELLOW NO. 6 INACTIVE INGREDIENT H77VEI93A8 TRANYLCYPROMINE SULFATE (TRANYLCYPROMINE SULFATE) TABLET [RISING PHARMACEUTICALS, INC.] 2 GELATIN INACTIVE INGREDIENT 2G86QN327L TRANYLCYPROMINE SULFATE (TRANYLCYPROMINE SULFATE) TABLET [RISING PHARMACEUTICALS, INC.] 2 LACTOSE INACTIVE INGREDIENT J2B2A4N98G TRANYLCYPROMINE SULFATE (TRANYLCYPROMINE SULFATE) TABLET [RISING PHARMACEUTICALS, INC.] 2 MAGNESIUM STEARATE INACTIVE INGREDIENT 70097M6I30 TRANYLCYPROMINE SULFATE (TRANYLCYPROMINE SULFATE) TABLET [RISING PHARMACEUTICALS, INC.] 2 TALC INACTIVE INGREDIENT 7SEV7J4R1U TRANYLCYPROMINE SULFATE (TRANYLCYPROMINE SULFATE) TABLET [RISING PHARMACEUTICALS, INC.] 2 TITANIUM DIOXIDE INACTIVE INGREDIENT 15FIX9V2JP TRANYLCYPROMINE SULFATE (TRANYLCYPROMINE SULFATE) TABLET [RISING PHARMACEUTICALS, INC.] 2
openFDA label cross-check# OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
Matched openFDA labels page 1 of 1 · 2 matching rows.